Carotid intima-media thickness in heterozygous familial hypercholesterolemia: Associated factors and changes following 1 year of treatment;Grosor de la íntima-media carotídea en la hipercolesterolemia familiar heterocigótica: Factores asociados y variación al año de tratamiento

Medicina Clinica

Volumn 133, Issue 4, 2009, Pages 121-126

  Lahoz, Carlos ^a   Mostaza, José M ^a   San Martín, Miguel A ^a   García Iglesias, María F ^a   Frías, Manuel ^a   García, Ángel ^a   Peraira, Roberto ^a   Laguna, Fernando ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Familial hypercholesterolemia; Intima media thickness; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION;

CAROTID ARTERIES; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 68149159370     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.02.052     Document Type: Article

References (29)

1. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
2. D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14
3. M.A. Austin, C.M. Hutter, R.L. Zimmern, and S.E. Humphries Familial hypercholesterolemia and coronary heart disease: A HuGE association review Am J Epidemiol 160 2004 421 429
4. C. Lahoz, and J.M. Mostaza Hipercolesterolemia familiar: ¿somos también diferentes en esto? Med Clin (Barc) 113 1999 533 534
5. J.H. Stein, C.E. Korcarz, R.T. Hurst, E. Lonn, C.B. Kendall, and E.R. Mohler Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine J Am Soc Echocardiogr 21 2008 93 111
6. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis Circulation 115 2007 459 467
7. J.J. Kastelein, and E. De Groot Ultrasound imaging techniques for the evaluation of cardiovascular therapies Eur Heart J 29 2008 849 858
8. O.S. Descamps, J.P. Gilbeau, X. Leysen, F. Van Leuven, and F.R. Heller Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia Eur J Clin Invest 31 2001 958 965
9. S. Tonstad, O. Joakimsen, E. Stensland-Bugge, L. Ose, K.H. Bonaa, and T.P. Leren Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects Eur J Clin Invest 28 1998 971 979
10. J.J. Kastelein, F. Akdim, E.S. Stroes, A.H. Zwinderman, M.L. Bots, and A.F. Stalenhoef Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
11. P.R. Nolting, E. De Groot, A.H. Zwinderman, R.J. Buirma, M.D. Trip, and J.J. Kastelein Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: Treatment with simvastatin Arch Intern Med 163 2003 1837 1841
12. T.J. Smilde, S. Van Wissen, H. Awollersheim, M.D. Trip, J.J.P. Kastelein, and A.F.H. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): A prospective, randomised, double-blind trial Lancet 357 2001 577 581
13. M. Junyent, M. Cofan, I. Nunez, R. Gilabert, D. Zambon, and E. Ros Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 26 2006 1107 1113
14. World Health Organization Familial hypercholesterolemia - report of a second WHO consultation 1999 World Health Organization Geneve
15. N.J. Bureau, and G. Roederer Sonography of Achilles tendon xanthomas in patients with heterozygous familial hypercholesterolemia Am J Roentgenol 171 1998 745 749
16. J.M. Hoeg, I.M. Feuerstein, and E.E. Tucker Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia Arterioscler Thromb 14 1994 1066 1074
17. R. Alonso, S. Castillo, F. Civeira, J. Puzo, J.J. De la Cruz, and M. Pocovi Hipercolesterolemia familiar heterocigota en España. Descripción de 819 casos no relacionados Med Clin (Barc) 118 2002 487 492
18. C. Garces, A.F. Rodríguez, A. Serrano, B.J. González, F. Almagro, and J.A. Garrido Manifestaciones clínicas de la hipercolesterolemia familiar heterocigota en España. Estudio de 301 casos de la zona centro y norte Med Clin (Barc) 114 2000 50 51
19. A.C. Jansen, E.S. Van Aalst-Cohen, M.W. Tanck, M.D. Trip, P.J. Lansberg, and A.H. Liem The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: Data in 2400 patients J Intern Med 256 2004 482 490
20. K.E. Heath, V. Gudnason, S.E. Humphries, and M. Seed The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia Atherosclerosis 143 1999 41 54
21. J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation Circulation 92 1995 290 295
22. M. Junyent, R. Gilabert, D. Zambón, I. Núñez, M. Vela, and F. Civeira The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias Arterioscler Thromb Vasc Biol 25 2005 2203 2208
23. P.S. Sidhu, R.P. Naoumova, V.M. Maher, J.E. MacSweeney, C.K. Neuwirth, and J.S. Hollyer The extracranial carotid artery in familial hypercholesterolaemia: Relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease J Cardiovasc Risk 3 1996 61 67
24. F.J. Raal, G.J. Pilcher, R. Waisberg, E.P. Buthelezi, M.G. Veller, and B.I. Joffe Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia Am J Cardiol 83 1999 1330 1333
25. T.J. Smilde, F.W. Van den Berkmortel, H. Wollersheim, H. Van Langen, J.J. Kastelein, and A.F. Stalenhoef The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia Eur J Clin Invest 30 2000 473 480
26. S. Van Wissen, T.J. Smilde, M.D. Trip, A.F. Stalenhoef, and J.J. Kastelein Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia Am J Cardiol 95 2005 264 266
27. M. Mercuri, M.G. Bond, C.R. Sirtori, F. Veglia, G. Crepaldi, and F.S. Feruglio Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study Am J Med 101 1996 627 634
28. E. De Groot, J.W. Jukema, A.D. Montauban van Swijndregt, A.H. Zwinderman, and R.G. Ackerstaff B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol 31 1998 1561 1567
29. J.W. Jukema, A.V. Bruschke, A.J. Van Boven, J.H. Reiber, E.T. Bal, and A.H. Zwinderman Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540